Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)
NCT04391114 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107
Last updated 2025-04-10
Summary
Benign prostatic hyperplasia (BPH), the non-malignant enlargement of the prostate gland, places pressure on the urethra and causes urination difficulties and bladder problems. Lower Urinary Tract Symptoms (LUTS) secondary to BPH is a common condition in aging men, with an overall prevalence of more than 50% in those older than 50 years of age. Men with LUTS often experience sexual dysfunction including ejaculatory loss, painful ejaculation, and erectile dysfunction, which among other complications can also lead to a decreased quality of life.
Holmium laser enucleation of the prostate (HoLEP), first reported by Fraundorfer et al in 1998, is a more recent step in the evolution of holmium laser prostatectomy. HOLEP offers patients the alternative of being treated endoscopically with minimal blood loss, short catheterization time, and decreased hospital stay.
One noted drawback to HoLEP, and the primary reason why it has yet to become the new standard for treatment of symptomatic BPH, is the complexity of this procedure, with a prolonged learning curve. Modifications to the procedure have thus been explored in order to address this limitation. The "Top-Down" HoLEP technique is a novel technique which offers potential benefits to the Traditional HoLEP procedure, including decreased complexity, a reduced learning curve, with anticipated improved continence.
This study will compare the operating time between the Top-Down Holmium Laser Enucleation of the prostate (HoLEP) and the Traditional HoLEP for the treatment of patients with symptomatic bladder outlet obstruction due to BPH in Northwestern Ontario.
Conditions
- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms
Interventions
- PROCEDURE
-
Traditional HoLEP
Holmium laser enucleation of the prostate (HoLEP), first reported by Fraundorfer et al in 1998, is a more recent step in the evolution of holmium laser prostatectomy. HoLEP is a safe and effective procedure which has demonstrated comparable results to TURP and open prostatectomy for patients with symptomatic enlarged prostate, with low morbidity and short hospital stay \[4\]. The improvement in outcome parameters is durable, and the late complications and reoperation rates reported are very low \[5\]. HoLEP is equally suitable for small, medium and larger prostate glands, with clinical outcomes that are independent of prostate size, unlike TURP. HOLEP offers patients the alterative of being treated endoscopically with minimal blood loss, short catheterization time, and decreased hospital stay \[6\].
- PROCEDURE
-
Top-Down HoLEP
The main difference between the Top-Down and Traditional approach is that the direction of lateral dissection begins from upwards to downwards. This could help in avoiding the overtraction of the mucosal strip overlying the posterior urethral sphincter, which theoretically leads to a decrease in the incidence of postoperative stress incontinence. Moreover, using the Top-Down approach should lead to a decrease in the incidence of lost enucleation planes, which results in decreasing the intraoperative time and decreasing the number of cases required to master the HoLEP technique.
Sponsors & Collaborators
-
Thunder Bay Regional Health Research Institute
lead OTHER
Principal Investigators
-
Hazem Elmansy, MD · Thunder Bay Regional Health Sciences Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-15
- Primary Completion
- 2026-06-01
- Completion
- 2026-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP
NCT05678452 ·Status: RECRUITING ·Phase: NA
-
HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study
NCT04178811 ·Status: COMPLETED
-
Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate
NCT00169767 ·Status: TERMINATED
-
En-bloc With Early Apical Release Versus Lobe-by-lobe LASER Enucleation of the Prostate
NCT07014969 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate
NCT07187180 ·Status: RECRUITING ·Phase: NA
-
HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial
NCT04143399 ·Status: COMPLETED ·Phase: NA
-
Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon
NCT01604148 ·Status: COMPLETED
-
HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia
NCT04561505 ·Status: COMPLETED ·Phase: NA
-
ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH
NCT03230721 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH
NCT00877669 ·Status: COMPLETED ·Phase: PHASE2
-
HoLEP Vs BPEP for Large Prostatic Adenoma
NCT04275076 ·Status: COMPLETED ·Phase: PHASE3
-
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
NCT06157164 ·Status: TERMINATED
-
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
NCT06531473 ·Status: RECRUITING ·Phase: NA
-
Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)
NCT03768765 ·Status: TERMINATED
-
Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy
NCT06865430 ·Status: RECRUITING ·Phase: NA
-
Laser Prostatectomy Database and Registry
NCT00159406 ·Status: ACTIVE_NOT_RECRUITING
-
Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP)
NCT04807296 ·Status: RECRUITING ·Phase: NA
-
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
NCT05768776 ·Status: ACTIVE_NOT_RECRUITING
-
Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP)
NCT01108367 ·Status: COMPLETED
-
The Effects of Holmium Laser Enucleation and Thulium Laser Enucleation on Continence, Urethral Stricture, and Sexual Function in Benign Prostatic Hyperplasia
NCT07334730 ·Status: NOT_YET_RECRUITING
-
HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH
NCT04935151 ·Status: COMPLETED ·Phase: NA
-
Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)
NCT05240001 ·Status: RECRUITING ·Phase: NA
-
SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia
NCT04826887 ·Status: COMPLETED
-
Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
NCT01781117 ·Status: COMPLETED ·Phase: NA
-
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH
NCT02332538 ·Status: COMPLETED ·Phase: NA